What is Syros Pharmaceuticals's official website?

Syros Pharmaceuticals's website is syros.com

How many employees are working in Syros Pharmaceuticals right now?

Syros Pharmaceuticals has 30 employees.

What is Syros Pharmaceuticals's industry?

Syros Pharmaceuticals's industry is Pharmaceutical Manufacturing

Who are Syros Pharmaceuticals's top competitors?

Syros Pharmaceuticals's top competitors are , , , , , ,

Syros Pharmaceuticals company information, Employees & Contact Information

Explore related pages

Syros Pharmaceuticals email format Syros Pharmaceuticals management contacts

Related company profiles:

Syros was committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies.

Employees: 30
Founded: -
Address: Cambridge , Ma 02140, Us
Phone: (617) 744-1340
Email: In****@****ros.com
Industry: Pharmaceutical Manufacturing
NAICS: Pharmaceutical and Medicine Manufacturing

Medicinal and Botanical Manufacturing

Pharmaceutical Preparation Manufacturing

In-Vitro Diagnostic Substance Manufacturing

Biological Product (except Diagnostic) Manufacturing
Website: syros.com
Keywords: commitment to our country. #veteransday.
HQ: Cambridge , MA
Competitors: Aura Biosciences, Kura Oncology, Inc., BridgeBio, ARS Pharmaceuticals, Inc., Mirum Pharmaceuticals, Inc., Cellectar Biosciences, Inc., Zealand Pharma, Cullinan Therapeutics, Actuate Therapeutics, Inc., Scholar Rock.

Syros Pharmaceuticals Questions

News

Failed Clinical Trial Forces Syros Pharmaceuticals Into Delisting and Wind-Down Operations - Stock Titan

Failed Clinical Trial Forces Syros Pharmaceuticals Into Delisting and Wind-Down Operations Stock Titan

Tamibarotene Plus Azacitidine Fails to Improve CR Rates in High-Risk, RARA+ MDS - OncLive

Tamibarotene Plus Azacitidine Fails to Improve CR Rates in High-Risk, RARA+ MDS OncLive

Syros Reports Third Quarter 2024 Financial Results and Provides a Business Update - Business Wire

Syros Reports Third Quarter 2024 Financial Results and Provides a Business Update Business Wire

Discovery of SY-5609: A Selective, Noncovalent Inhibitor of CDK7 - ACS Publications

Discovery of SY-5609: A Selective, Noncovalent Inhibitor of CDK7 ACS Publications

Flagship Pioneering Names Dr. Nancy Simonian, CEO of Syros, as Recipient of the 2019 Pioneering Leader Award - PR Newswire

Flagship Pioneering Names Dr. Nancy Simonian, CEO of Syros, as Recipient of the 2019 Pioneering Leader Award PR Newswire

Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - FinancialContent

Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) FinancialContent

Syros Reports First Quarter 2024 Financial Results and Provides a Corporate Update - Business Wire

Syros Reports First Quarter 2024 Financial Results and Provides a Corporate Update Business Wire

Syros Reports Second Quarter 2024 Financial Results and Provides a Business Update - Stock Titan

Syros Reports Second Quarter 2024 Financial Results and Provides a Business Update Stock Titan

FDA Grants Fast Track Designation to Tamibarotene/Azacitidine/Venetoclax for RARA-Overexpressed AML - OncLive

FDA Grants Fast Track Designation to Tamibarotene/Azacitidine/Venetoclax for RARA-Overexpressed AML OncLive

Syros Announces Pricing of $45.0 million Underwritten Offering of Common Stock and Pre-Funded Warrants - Business Wire

Syros Announces Pricing of $45.0 million Underwritten Offering of Common Stock and Pre-Funded Warrants Business Wire

Companies like Syros Pharmaceuticals

Top Syros Pharmaceuticals Employees

Laverne Auguste, BSBA, MBA

n/a

Boston, Massachusetts, United States, United States

View

5
takeda.com, bostonpharmaceuticals.com, verizon.net, ipi.com, syros.com

6 +161720XXXXX
Conley Chee

Chief Executive Officer Syros

New York City Metropolitan Area, United States, United States

View

3
hotmail.com, novartis.com, syros.com
Rashmi Bist, M.Pharm, RAC (US)

Regulatory Affairs Professional

Sunnyvale, California, United States, United States

View
Douglass Fahnoe

n/a

Waltham, Massachusetts, United States, United States

View

2
pfizer.com, syros.com

1 +186062XXXXX

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles

Get direct phone numbers & mobile contacts

Access company data & employee information

Works directly on LinkedIn - no copy/paste needed

Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Learn More

How It Works

Get a Free Account

Search the #1 Contact Database

Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.

Use our AI-Powered Email Finder

Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.

Have a look at Aeroleads Data

Browse our Data

Company Search

a b c d e f g h i j k l m n o p q r s t u v w x y z

Profile Search

a b c d e f g h i j k l m n o p q r s t u v w x y z

List Search

a b c d e f g h i j k l m n o p q r s t u v w x y z

Syros Pharmaceuticals company information, Employees & Contact Information

Explore related pages

Company Details

Syros Pharmaceuticals Questions

What is Syros Pharmaceuticals's helpline number?

What is Syros Pharmaceuticals's official website?

What is Syros Pharmaceuticals's LinkedIn profile?

How many employees are working in Syros Pharmaceuticals right now?

What is Syros Pharmaceuticals's industry?

What are Syros Pharmaceuticals's top competitors?

What is Syros Pharmaceuticals's support email address?

What are Syros Pharmaceuticals's categories?

When was Syros Pharmaceuticals founded?

News

Failed Clinical Trial Forces Syros Pharmaceuticals Into Delisting and Wind-Down Operations - Stock Titan

Tamibarotene Plus Azacitidine Fails to Improve CR Rates in High-Risk, RARA+ MDS - OncLive

Syros Reports Third Quarter 2024 Financial Results and Provides a Business Update - Business Wire

Discovery of SY-5609: A Selective, Noncovalent Inhibitor of CDK7 - ACS Publications

Flagship Pioneering Names Dr. Nancy Simonian, CEO of Syros, as Recipient of the 2019 Pioneering Leader Award - PR Newswire

Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - FinancialContent

Syros Reports First Quarter 2024 Financial Results and Provides a Corporate Update - Business Wire

Syros Reports Second Quarter 2024 Financial Results and Provides a Business Update - Stock Titan

FDA Grants Fast Track Designation to Tamibarotene/Azacitidine/Venetoclax for RARA-Overexpressed AML - OncLive

Syros Announces Pricing of $45.0 million Underwritten Offering of Common Stock and Pre-Funded Warrants - Business Wire

Companies like Syros Pharmaceuticals

Cullinan Therapeutics

Kura Oncology, Inc.

Scholar Rock

Aura Biosciences

Cellectar Bioscience...

Ars Pharmaceuticals,...

Bridgebio

Zealand Pharma

Mirum Pharmaceutical...

Actuate Therapeutics...

Top Syros Pharmaceuticals Employees

Laverne Auguste, BSBA, MBA

n/a

Conley Chee

Chief Executive Officer Syros

Rashmi Bist, M.Pharm, RAC (US)

Regulatory Affairs Professional

Douglass Fahnoe

n/a

Free Chrome Extension

Aero Online

Select data to include:

How It Works

Get a Free Account

Search the #1 Contact Database

Use our AI-Powered Email Finder

Have a look at Aeroleads Data